COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,050 Articles (22,627 medRxiv, 8,423 bioRxiv)

Most recent first Previous |  Page 1790: Articles 17891-17900  | Next

Survey of symptoms following COVID-19 vaccination in India
Rajeev Jayadevan, Ramesh Shenoy, Anithadevi TS
10.1101/2021.02.08.21251366 — Posted: 2021-02-12
Results of an early second PCR test performed on SARS-CoV-2 positive patients may indicate risk for severe COVID-19
Barak Mizrahi, Maytal Bivas-Benita, Nir Kalkstein, Pinchas Akiva, Chen Yanover, Yoav Yehezkelli, Yoav Kessler, Sharon Hermoni Alon, Eitan Rubin, Gabriel Chodick
10.1101/2021.02.09.21251371 — Posted: 2021-02-12
SARS-CoV-2 re-infection risk in Austria
Pilz, S., Chakeri, A., Ioannidis, J. P. A., Richter, L., Theiler-Schwetz, V., Trummer, C., Krause, R., Allerberger, F.
10.1101/2021.02.08.21251362 — Posted: 2021-02-12 Discussion: Onsite
Anti-SARS-CoV-2 seropositivity among medical students in Copenhagen
Madsen, J. R., Nielsen, J. P. S., Fogh, K., Hansen, C. B., Nielsen, P. B., Lange, T., Hasselbalch, R. B., Garred, P., Iversen, K.
10.1101/2021.02.09.21251421 — Posted: 2021-02-12
Associations between measures of social distancing and SARS-CoV-2 seropositivity: a nationwide population-based study in the Netherlands
Vos, E. R. A., van Bove, M., den Hartog, G., Backer, J. A. , Klinkenberg, D., van Hagen, C. C. E., Boshuizen, H., van Binnendijk, R. S. , Mollema, L., van der Klis, F. R. M., de Melker, H. E.
10.1101/2021.02.10.21251477 — Posted: 2021-02-12
Performance characteristics of five antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparison
Baro, B., Rodo, P., Ouchi, D., Bordoy, A. E., Saya Amaro, E. N., Salsench, S. V., Molinos, S., Alemany, A., Ubals, M., Corbacho-Monné, M., Millat-Martinez, P., Marks, M., Clotet, B., Prat, N., Ara, J., Vall-Mayans, M., G-Beiras, C., Bassat, Q., Blanco, I., Mitjà, O.
10.1101/2021.02.11.21251553 — Posted: 2021-02-12
SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization
Hoffmann, M., Zhang, L., Krueger, N., Graichen, L., Kleine-Weber, H., Hofmann-Winkler, H., Kempf, A., Nessler, S., Riggert, J., Winkler, M. S., Schulz, S., Jaeck, H.-M., Poehlmann, S.
10.1101/2021.02.12.430998 — Posted: 2021-02-12
Virus transmission by ultrasonic scaler and its prevention by antiviral agent
Fidler, A., Steyer, A., Gaspersic, R.
10.1101/2021.02.10.430630 — Posted: 2021-02-12
IN VITRO ANTI-VIRAL ACTIVITY OF HEXETIDINE (BACTIDOL) ORAL MOUTHWASH AGAINST HUMAN CORONAVIRUS OC43 ANDINFLUENZA A (H1N1) VIRUS
Altura, M. T., Ngelangel, C. A.
10.1101/2021.02.11.430728 — Posted: 2021-02-12 Discussion: Onsite
Single-cell sequencing of plasma cells from COVID-19 patients reveals highly expanded clonal lineages produce specific and neutralizing antibodies to SARS-CoV-2
Ehling, R. A., Weber, C. R., Mason, D. M., Friedensohn, S., Wagner, B., Bieberich, F., Kapetanovic, E., Vazquez-Lombardi, R., Di Roberto, R. B., Hong, K.-L., Wagner, C., Sheward, D. J., Murrell, B., Yermanos, A., Cuny, A., Savic, M., Rudolf, F., Reddy, S. T.
10.1101/2021.02.12.430940 — Posted: 2021-02-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).